PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.19%
Revenue growth under 50% of BIDU's 52.59%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
10.70%
Gross profit growth under 50% of BIDU's 61.43%. Michael Burry would be concerned about a severe competitive disadvantage.
7.44%
EBIT growth below 50% of BIDU's 336.56%. Michael Burry would suspect deeper competitive or cost structure issues.
7.44%
Operating income growth under 50% of BIDU's 336.56%. Michael Burry would be concerned about deeper cost or sales issues.
-7.15%
Negative net income growth while BIDU stands at 382.12%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-8.62%
Negative EPS growth while BIDU is at 109.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-7.74%
Negative diluted EPS growth while BIDU is at 300.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.74%
Share reduction more than 1.5x BIDU's 150.31%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.22%
Diluted share reduction more than 1.5x BIDU's 2.38%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
17.94%
OCF growth of 17.94% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
20.64%
FCF growth of 20.64% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
1327.38%
10Y revenue/share CAGR above 1.5x BIDU's 143.15%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1327.38%
5Y revenue/share CAGR above 1.5x BIDU's 143.15%. David Dodd would look for consistent product or market expansions fueling outperformance.
1327.38%
3Y revenue/share CAGR above 1.5x BIDU's 143.15%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1542.42%
Net income/share CAGR above 1.5x BIDU's 292.19% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1542.42%
5Y net income/share CAGR above 1.5x BIDU's 292.19%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1542.42%
3Y net income/share CAGR above 1.5x BIDU's 292.19%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.33%
AR growth is negative/stable vs. BIDU's 40.62%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
16.36%
Similar asset growth to BIDU's 15.53%. Walter Schloss finds parallel expansions or investment rates.
13.41%
Under 50% of BIDU's 106.63%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-77.79%
We’re deleveraging while BIDU stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
20.60%
R&D growth drastically higher vs. BIDU's 31.49%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
14.17%
SG&A declining or stable vs. BIDU's 36.18%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.